Literature DB >> 9559891

Effect of 17beta-oestradiol on cytokine-induced nitric oxide production in rat isolated aorta.

K Kauser1, D Sonnenberg, P Diel, G M Rubanyi.   

Abstract

1. Studies were performed on isolated aortic rings without endothelium to investigate the effect of 17beta-oestradiol on cytokine-induced nitric oxide production by the inducible nitric oxide synthase (iNOS). 2. Treatment of the isolated aortic rings with interleukin-1beta (IL-1beta, 20 micro ml(-1)) led to the expression of iNOS mRNA and protein, as well as significant nitrite accumulation in the incubation media and suppression of phenylephrine (1 nM-10 microM)-evoked contraction. 3. Cycloheximide (1 microM), a protein synthesis inhibitor, prevented iNOS protein expression, nitrite accumulation and the suppression of contractility by IL-1beta on the isolated aortic rings. 17Beta-oestradiol (1 nM-10 microM) and the partial oestrogen receptor agonist 4-OH-tamoxifen (1 nM-10 microM) produced concentration-dependent inhibition of IL-1beta-induced nitrite accumulation and restored vasoconstrictor responsiveness to phenylephrine, similar to the iNOS inhibitor aminoguanidine (100 microM). 4. Semiquantitative PCR demonstrated decreased iNOS mRNA in the IL-1beta-induced and 17beta-oestradiol-treated rings. Western blot analysis of rat aorta homogenates revealed that 17beta-oestradiol treatment resulted in a reduction in IL-1beta-induced iNOS protein level. 5. Incubation with tumour necrosis factor alpha (TNF alpha, 1 ng ml(-1)) resulted in significant nitrite accumulation in the incubation media and suppression of the smooth muscle contractile response to phenylephrine, similar to IL-1beta. The effects of TNF alpha were also inhibited by co-incubation of the rings with 17beta-oestradiol and 4-OH-tamoxifen (1 microM). 6. The anti-transforming growth factor-beta1 (TGF-beta1) antibody, which inhibited TGF-beta1-induced suppression of nitrite production from IL-1beta-treated vascular rings, did not affect the inhibitory action of 17beta-oestradiol, suggesting that the effect of oestrogen on iNOS inhibition was not mediated by TGF-beta1. 7. These results show that the ovarian sex steroid, 17beta-oestradiol is a modulator of cytokine-induced iNOS activity in rat vascular smooth muscle and its mechanism of action involves decrease of iNOS mRNA and protein.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9559891      PMCID: PMC1565268          DOI: 10.1038/sj.bjp.0701715

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

Review 1.  Sex differences in physiological reactivity to acute psychosocial stress in adolescence.

Authors:  Sarah Ordaz; Beatriz Luna
Journal:  Psychoneuroendocrinology       Date:  2012-01-27       Impact factor: 4.905

2.  Role of inducible nitric oxide synthase in endothelium-independent relaxation to raloxifene in rat aorta.

Authors:  Chi Ming Wong; Chak Leung Au; Suk Ying Tsang; Chi Wai Lau; Xiaoqiang Yao; Zongwei Cai; Arthur Chi-Kong Chung
Journal:  Br J Pharmacol       Date:  2017-02-27       Impact factor: 8.739

3.  The role of estrogen receptor subtypes in ameliorating hepatic injury following trauma-hemorrhage.

Authors:  Tomoharu Shimizu; Huang-Ping Yu; Takao Suzuki; László Szalay; Ya-Ching Hsieh; Mashkoor A Choudhry; Kirby I Bland; Irshad H Chaudry
Journal:  J Hepatol       Date:  2007-02-12       Impact factor: 25.083

4.  Estrogen regulates transcription factors STAT-1 and NF-kappaB to promote inducible nitric oxide synthase and inflammatory responses.

Authors:  Rujuan Dai; Rebecca A Phillips; Ebru Karpuzoglu; Deena Khan; S Ansar Ahmed
Journal:  J Immunol       Date:  2009-11-04       Impact factor: 5.422

5.  Oxidative stress and compartment of gene expression determine proatherosclerotic effects of inducible nitric oxide synthase.

Authors:  Padmapriya Ponnuswamy; Eva Ostermeier; Angelika Schröttle; Jiqiu Chen; Paul L Huang; Georg Ertl; Bernhard Nieswandt; Peter J Kuhlencordt
Journal:  Am J Pathol       Date:  2009-06       Impact factor: 4.307

6.  Comparative study of the binding characteristics to and inhibitory potencies towards PARP and in vivo antidiabetogenic potencies of taurine, 3-aminobenzamide and nicotinamide.

Authors:  Kashyap G Pandya; Maulik R Patel; Cesar A Lau-Cam
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

7.  Abnormalities associated with progressive aortic vascular dysfunction in chronic kidney disease.

Authors:  Omar Z Ameer; Rochelle Boyd; Mark Butlin; Alberto P Avolio; Jacqueline K Phillips
Journal:  Front Physiol       Date:  2015-05-19       Impact factor: 4.566

8.  Distinct roles of estrogen receptor-alpha and beta in the modulation of vascular inducible nitric-oxide synthase in diabetes.

Authors:  Andrea Cignarella; Chiara Bolego; Valeria Pelosi; Clara Meda; Andrée Krust; Christian Pinna; Rosa Maria Gaion; Elisabetta Vegeto; Adriana Maggi
Journal:  J Pharmacol Exp Ther       Date:  2008-10-02       Impact factor: 4.030

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.